Cleveland, Ohio—December 5, 2023— MIM Software Inc., a leading global provider of medical imaging software, announced US Food and Drug Administration (FDA) clearance of its newest AI auto-contouring solution, Contour ProtégéAI+™.
Unlike other auto-contouring tools, Contour ProtégéAI+ requires no clicks. Contouring of lymph node level and OAR structures starts automatically, and no manual intervention is required to launch. Results are exported directly to the TPS or MIM for review. This gives dosimetrists and physicians more time to create quality treatment plans for their patients.
“Cancer treatment planning teams should have as much time as possible to focus on developing precise, individualized treatment plans,” said Jay Obman, Product Manager at MIM Software Inc. “The MIM team is thrilled that zero-click auto-contouring of lymph node level and OAR structures with Contour ProtégéAI+ will save clinicians the time-consuming manual effort that comes with other auto-contouring tools.”
MIM Software Inc. is headquartered in Cleveland, OH, with international offices in Beijing, Chengdu, and Brussels.
MIM Software sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies. The company’s products are used in over 3,500 centers worldwide.
MIM Software is committed to enhancing patient care by providing customer-centered and innovative imaging solutions in the fields of Radiation Oncology, Radiology, Nuclear Medicine, Theranostics, Interventional Radiology, and Urology.
Email: bcarruthers@mimsoftware.com
Phone: 216-455-0610